A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
- Publisher
- BRITISH JOURNAL OF CANCER
- Language
- 영어
- ISSN
- 0007-0920
- Citation Volume
- 124
- Citation Number
- 2
- Citation Start Page
- 383
- Citation End Page
- 390
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.